Reflex sympathetic dystrophy (RSD) syndrome has been recognized clinically for many years. It is most often initiated by trauma to a nerve, neural plexus, or soft tissue. Diagnostic criteria are the presence of regional pain and other sensory changes following a noxious event. The pain is associated with changes in skin colour, skin temperature, abnormal sweating, oedema, and sometimes motor abnormalities. The clinical course is commonly divided into three stages: first (acute or hyperaemic), second (dystrophic or ischaemic), and third (atrophic) stage. The diagnosis is primarily clinical, but roentgenography, scintigraphy, thermography, electromyography and assessment of nerve conduction velocity can help to confirm the diagnosis. Although a wide variety of treatments have been recommended, the only therapies found to be effective in large studies aim at interfering with the activity of the sympathetic nervous system. To this end, efferent sympathetic nerve activity can be interrupted surgically or chemically. Alternatively, adrenoceptor blockers may be used to relieve pain. Numerous theories have been proposed to explain the pathophysiology. Sympathetic dysfunction, which often has been purported to play a pivotal role in RSD, has been suggested to consist of an increased rate of efferent sympathetic nerve impulses towards the involved extremity induced by increased afferent activity. However, the results of several experimental studies suggest that sympathetic dysfunction consists of supersensitivity to catecholamines induced by (partial) autonomic denervation. Besides, it has been suggested that excitation of sensory nerve fibres at axonal level causes release of neuropeptides at the peripheral endings of these fibres. These neuropeptides may induce vasodilation, increase vascular permeability, and excite surrounding sensory nerve fibres -a phenomenon referred to as neurogenic inflammation. At the level of the central nervous system, it has been suggested that the increased input from peripheral nociceptors alters the central processing mechanisms. Key words: causalgia; neurogenic inflammation; partial nerve injury; peripheral nervous system; reflex sympathetic dystrophy; sympathetic nervous system tory. This review outlines the signs and symptoms of RSD. An overview of diagnostic tests and therapeutic options is provided. Pathophysiologic mechanisms which have been purported to underly the syndrome are discussed.
Introduction
The reflex sympathetic dystrophy (RSD) syndrome has long been recognized clinically. In 1864, Weir Mitchell et al 1 reported that gunshot wound injuries of peripheral nerves may cause pain as well as changes in colour and temperature of the skin within the affected extremity. Despite this, basic research has been sparse with little support from clinical studies to reveal the pathophysiology of RSD. In addition, there has been considerable disagreement regarding diagnostic criteria. Consequently, RSD is often not recognized and is treated inappropriately or with delay, and patients may undergo various types of treatment which frequently have little rational basis. It is not surprising that the results of these types of treatment are often not satisfac-
Nomenclature
In their first report, Mitchell et al designated the syndrome currently known as RSD, 'erythromelalgia', 1 a designation which 3 years later was changed into 'causalgia'. 2 Since then, several similar clinical syndromes have been given different names because of either a predominant clinical feature or a precipitating event. Today the term causalgia is often used to describe a symptom complex occurring after an established lesion of a large peripheral nerve, whereas RSD is employed for patients with soft tissue injury without established injury to a large peripheral nerve. 3 A revised taxonomic system for RSD was presented in 1994. 4 Syndromes previously designated RSD or causalgia were classified under the neutral umbrella term complex regional pain syndrome (CRPS), which is based completely on clinical criteria. Proposed diagnostic criteria for CRPS are the presence of regional pain (spontaneous and evoked) and other sensory changes following a noxious event. The pain is associated with changes in skin colour, skin temperature, abnormal sweating, oedema, and sometimes motor abnormalities. Two subtypes of CRPS have been defined: CRPS type I, which corresponds to RSD, and CRPS type II, which corresponds to causalgia. This review refrains from using the traditional separation between RSD and causalgia for various reasons. First, although according to the traditional definition of RSD evidence of nerve damage is lacking, no specific clinical or electrodiagnostic cri-teria have been defined in order to rule out nerve injury. Secondly, clinical characteristics of RSD patients do not differ from those of causalgia patients, which suggests that these patient groups share similar pathophysiologic mechanisms.
Precipitating events
RSD is associated with a wide variety of precipitating events ( Table 1 ). The common mechanism of these events has been purported to be injury to or disease of neural tissue, 5 either centrally (brain, spinal cord) or peripherally (dorsal root ganglion, large peripheral nerves and terminal nerve twigs). The involvement of neural tissue in RSD is supported by the observation that the syndrome may develop in an extremity following injury 6 or disease 7 of the central nervous system. Usually, RSD is easily diagnosed because the precipitating event is an obvious trauma to a major nerve trunk, to tissues in close proximity to a major nerve trunk or to regions rich in nerve endings. However, in some patients RSD may be misdiagnosed because of a lack of correlation between the severity of the injury and the severity of the resultant syndrome. In others, a precipitating event may even be untraceable. In order to prevent There is very little information available regarding the overall incidence of RSD in the general population. Moreover, considerable differences in incidence of RSD have been reported for essentially similar injuries. For example, in patients with a fracture of the distal radius some studies have reported an incidence of less than 10%, 8, 9 whereas others observed development of RSD in 25% or more of the cases. 10, 11 These inconsistent findings may relate to, among other factors, the use of different diagnostic criteria. It has been reported that RSD occurs most frequently in women over the age of 50 years. 7 This higher incidence may be related to the higher incidence of fractures in this age group. Other studies have provided (indirect) evidence for familial predisposition 12 and increased genetic susceptibility. 13 Speculation exists on whether psychological factors predispose to the development of RSD. A recent meta-analysis of 29 papers containing original psychological information of any type revealed no evidence for specific psychopathology in RSD patients. 14 Consequently, the author concluded that the specific personality traits noted in RSD are a result (and thus not a cause) of the patients' (often unbearable) ongoing pain and suffering.
Signs and symptoms
RSD syndrome is associated with a large number of signs and symptoms, which may show extreme variation in presence and severity, not only between patients but also in time. Signs and symptoms can be categorized into autonomic, sensory, motor and trophic disturbances.
Autonomic dysfunction in RSD patients may be characterized by abnormalities of colour (red, pale, or cyanotic) and temperature (warm or cold) of the skin. All these parameters may demonstrate short-term variability. Less frequently, sweating is changed (anhydrosis or hyperhydrosis). Another important feature of RSD is oedema, which may be observed at the site of injury as well as distal to it and which may increase following dependency of the affected extremity.
For most RSD patients, stimulus-independent persistent pain is the most troublesome feature. It is described as burning in character with a palmar or plantar predominance, and may be out of proportion to the initiating event. It may be limited to the distribution of a posterior root or a peripheral nerve. Alternatively, pain may not be confined to such a distribution, which may indicate injury to terminal nerve twigs. Such a spread of sensory abnormalities may be related to the observation that rats with an experimental peripheral mononeuropathy exhibit sensory abnormalities outside the distribution of the lesioned nerve. 15 It has been suggested that this phenomenon relates to a peripheral nerve injury-evoked dysfunction of pain processing neurons in the central nervous system. The pain may radiate proximally or distally and involve the whole extremity. In some cases, even the contralateral extremity may become involved (mirror phenomenon). Taken together, these observations indicate that an atypical distribution of sensory abnormalities does not argue against the diagnosis of RSD. In addition to stimulus-independent persistent pain, a wide range of stimulus-induced sensory abnormalities may be present such as hyperalgesia (lowered pain threshold to noxious stimulus and enhanced pain perception), allodynia (pain elicited by a normally non-noxious stimulus), hyperpathia (delayed over-reaction and after-sensation to a stimulus), and slow temporal summation of mechanical allodynia. Hyperalgesia and allodynia may result from thermal as well as mechanical stimuli. Hyperaesthesia (increased sensitivity), hypaesthesia (decreased sensitivity, numbness), and paraesthesia have also been reported. All of these sensory abnormalities may be exacerbated by stress, exercise, or cold.
The motor disorder of RSD may consist of a limited range of active movement, weakness, rapid fatiguability, dystonia, paresis, and altered reflexes. Some patients develop muscle spasms or tremor of a limb.
In RSD patients, nail and hair may exhibit an abnormal growth rate as well as an abnormal consistency (brittle nails with ridges and coarse hair). The skin may become smooth and glossy, with a decrease or loss of normal wrinkles and creases. Rarely, skin pigment changes and/or ulcers are observed. Trophic changes of other tissues may also occur. These include atrophic changes of subcutaneous tissues (pencil-point or tapered digits), and muscular wasting. At end-stages of the syndrome, contractures of tendons often occur and joints may become ankylosed. 
Onset and course
The onset of RSD has been reported to vary considerably. When provoked by external trauma, the onset is usually rapid, but the onset of symptoms may vary from immediately to several weeks after injury. When the initiating event is non-traumatic, the onset may be slower and more insidious. The clinical course of RSD has commonly been divided into three stages: first (acute or hyperaemic), second (dystrophic or ischaemic), and third (atrophic) stage. 16 The various authors do not report identical signs and symptoms at each stage of RSD. Moreover, signs and symptoms of RSD may demonstrate extreme short-term variability. Nevertheless, a general pattern of the progression in stages may be distinguished. During the first (acute or hyperaemic) stage the skin of the affected extremity is usually red and warm. Oedema, which may be observed at the site of injury as well as distal to it, is ordinarily most pronounced at this stage. In the second (dystrophic or ischaemic) stage, the skin of the affected extremity may become moist, cold and pale (or even cyanotic), although short-term fluctuations of skin temperature (from abnormally cold to abnormally warm and vice versa) have been reported. There is spreading of oedema, increasing stiffness of the joints and muscular wasting. The hair may become coarse, and the nails may show ridges and become brittle. The third (atrophic) stage is characterized by an ongoing cold sensation as well as marked trophic changes that eventually may become irreversible. Muscles, tendons, subcutaneous tissues, skin and skin appendages may show increasingly trophic changes. There is extreme weakness and limitation of motion in virtually all of the involved joints, which finally may become ankylosed. Although the duration of each stage has been indicated to vary from 3 to 6 months, 7 the actual length may vary considerably, lasting anywhere from weeks to years. 5
Microcirculatory abnormalities
Various studies have demonstrated skin blood flow abnormalities, not only in the clinically affected, 17 but also in the clinically unaffected extremity 18 of RSD patients. The skin blood flow abnormalities on the clinically affected side do not involve major artery disease and, hence, are solely of microcirculatory origin. 19 Laser Doppler flowmetry enables non-invasive evaluation of the skin microcirculation. The flow signal recorded with this technique originates predominantly (Ͼ95%) from the subpapillary arteriolar and venular plexus as well as the interconnecting arterio-venular anastomoses. 20 These vessels are mainly involved in thermoregulation. 21 It has been shown that skin blood flow at this level of the skin microcirculation is increased at an early stage and decreased at later stages of RSD. 17, 22 The decrease at later stages was shown to result from functional vasospasm rather than from structural vessel wall changes. 19 Another means of studying skin blood flow non-invasively involves capillary (video) microscopy. By means of this technique, the superficial capillaries in the dermal papillae, which supply nutrition to the skin, can be directly visualized. Thus, capillary haemodynamic and morphologic parameters can be measured. In RSD patients, it has been demonstrated that skin blood flow at this level of the skin microcirculation is reduced at stages II and III. 17
Diagnosis
The ability to diagnose RSD depends primarily on clinical assessment. Various clinical investigations may be of help in confirming the diagnosis, determining stage and severity, and yielding objective baseline data that can be employed to monitor a patient's response to therapy.
There are no consistent routine laboratory findings in RSD patients: erythrocyte sedimentation rate and leucocyte counts are within the normal range. 23 Roentgenographic studies, which were the first to confirm the diagnosis of RSD, demonstrate patchy demineralization of the epiphyses of long bones and also of the bones of hands and feet. Soft tissues may be swollen and reticulated in appearance. Fine-detail roentgenography reveals subperiostal bone resorption, striation, and tunnelling in the cortices, as well as large excavations and tunnelling of the endosteal surface. 24 However, it should be remembered that in RSD patients patchy demineralization is generally not appreciated until the syndrome advances to the second stage. Besides, the aforementioned changes are not specific to RSD and may also be seen in other conditions with increased bone turnover. Sensitivity and specificity of roentgenography in RSD patients have been reported to be 69% and 71%, respectively. 25 RSD is associated with injury to neural tissue. Consequently, it would be expected that electromyography (EMG) and assessment of nerve conduction velocity (NCV) may be of diagnostic use. The percentage of RSD patients demonstrating EMG or NCV abnormalities usually ranges from 50% to 90%. [26] [27] [28] [29] Other studies, however, failed to demonstrate electrophysiologic evidence of nerve dysfunction. 30, 31 This variability may relate to differences in diagnostic criteria and it should be realized that EMG and NCV provide information on the conductive properties of nerve fibres and therefore do not exclude excitation of these fibres.
Thermography may also be of help in establishing the diagnosis of RSD. Skin temperature within the affected extremity has been reported to be increased at stage I, normalized at stage II and decreased at stage III of RSD. 17 The three-phase bone scanning technique enables evaluation of total extremity perfusion, which was found to be increased at stage I, normalized at stage II and decreased at stage III. 32 The sensitivity and specificity of scintigraphy in RSD patients were reported to be 60% and 86% respectively. 25 Various studies have reported on histopathologic findings in RSD. In general these studies report varying degrees of inflammation in synovial 31 and skeletal muscle 33 biopsies. The latter additionally demonstrated reduced cholineesterase reactions, pathologic changes of motor endplates and reduced adrenergic innervation. 34 Histologic examination of bone revealed signs of active remodelling of both the cancellous bone and the cortex. 35 Vascular Medicine 1998; 3: 207-214
Differential diagnosis
Microcirculatory abnormalities similar to those observed in RSD patients may occur in various other diseases, for example Raynaud's phenomenon, a condition in which symmetrical, triphasic discolouration of hands and fingers occurs. 36 This phenomenon may exist with or without underlying (systemic auto-immune) disease, in which case it is categorized as primary or secondary, respectively. 37 Raynaud's phenomenon may be differentiated from RSD because of its symmetrical distribution as well as its characteristic triphasic pattern of skin blood flow abnormalities. In addition, secondary Raynaud's phenomenon is characterized by morphologic abnormalities of nail fold capillaries in the affected extremities, which are not present in RSD. 37 Acrocyanosis is characterized by an uni-or bilateral permanent cyanosis of hands and fingers, without the existence of an underlying disease. Asphyxia manus et digitorum is depicted by a local, sharply bordered discolouration of one or more fingers. Acrocyanosis and asphyxia manus et digitorum may be differentiated from RSD because the latter is usually preceded by some kind of trauma. Also, various features may be present in RSD which are not observed in acrocyanosis or asphyxia manus et digitorum such as abnormal nail or hair growth and abnormal sweat excretion. In patients presenting with pain, cold sensation and trophic changes of the skin, the presence of limb ischaemia due to atherosclerosis should also be considered, although major artery disease is rarely localized in the upper extremity, whereas RSD is localized predominantly in the upper extremity. In addition to physical examination, several diagnostic tests, such as angiography and Doppler ultrasonography, are available in order to exclude the presence of major artery disease. Pain and inflammatory signs related to rheumatologic abnormalities may be another source of diagnostic difficulties, especially when these are present unilaterally.
Treatment
The most effective preventative measure is efficient control of pain and as early mobilization as possible. A wide variety of therapies have been recommended for treatment of RSD. It is generally agreed that an important factor in the effective treatment of RSD is early recognition and treatment since patients with long-standing duration of disease are less likely to respond well. 38 Several treatments have isolated reports of success. Among these are physical therapy, 39 corticosteroids, 40 and transcutaneous nerve stimulation. 41 The only therapy found to be effective for RSD in large studies is aimed at interruption of the activity of the sympathetic nervous system. Other treatments were found to be successful in isolated reports, but none has been proven effective in large studies.
Interruption of the sympathetic nervous system activity can be achieved in several ways. Bier block is a technique utilized for regional anaesthesia. The limb is raised and separated from the systemic circulation by a tourniquet. Then substances are injected into the limb intravenously distal to the cuff for a limited period of time after which the tourniquet is released. Hannington-Kiff thus injected guanethidine sulphate, which interferes with the transport of norad-renaline while depleting storage in sympathetic nerve terminals. Various authors have reported excellent results for pain relief. 42, 43 A disadvantage of this technique is that the duration of pain relief usually lasts only 12-36 h. Another method of interfering with efferent sympathetic nerve activity involves paravertebral sympathetic ganglion blockade. 44 Again, a major disadvantage of this technique is that relief is only transient. 45 In those cases demonstrating transient relief of complaints following ganglion blocks, paravertebral sympathetic ganglionectomy is likely to provide permanent relief. The reported incidence of complete relief varies from 58% to 100%, whereas the duration of follow-up in these studies varied from 6 months to 17 years. [46] [47] [48] Interfering with the activity of the sympathetic nervous system can be achieved not only through interruption of efferent sympathetic nerve impulses but also through blockade of adrenoceptors. Ghostine et al, 49 in a series of 27 patients with RSD of short duration (less than 6 weeks), investigated the effects of phenoxybenzamine, a non-selective ␣-adrenoceptor blocker. The duration of treatment was usually 6-8 weeks, whereas the duration of follow-up ranged from 6 months to 6 years. Total resolution was achieved in all cases. Side-effects were minimal and transient, consisting predominantly of mild orthostatic hypotension and ejaculatory problems. In line with these findings, intravenous administration of the non-selective ␣adrenoceptor blocker phentolamine may relieve pain. 50 Interestingly, blockade of ␤-adrenoceptors does not relieve symptoms in RSD patients. 51 Overall, these data suggest that the ␣-, but not the ␤-adrenoceptor is involved in mediation of pain.
Pathophysiologic mechanisms underlying RSD
It has been suggested that the high levels of discharge originating in sensory nerve fibres within the affected extremity of RSD patients may induce changes in the central nervous system. Consequently, processing of input at this first relay in the pathway of sensory impulses may be altered. Although these central changes may play an important role, this review will focus only on changes occurring at the level of the peripheral nervous system.
Dysfunction of the sympathetic nervous system
The presence of abnormal temperature and colour of the skin as well as altered sweat excretion in the affected extremities of RSD patients suggests altered (efferent) function of the sympathetic nervous system. The hypothesis that in RSD patients an abnormal interaction exists between the sensory and sympathetic nervous system is based on the observation that both surgical 52 and chemical 53 sympathectomy relieve pain. This observation has led to the theory that in RSD patients a vicious circle of events is generated, which results in an increased rate of efferent sympathetic nerve impulses towards the involved extremity. According to this theory, injury to peripheral tissues or nerves leads to increased afferent activity from the damaged periphery to the spinal cord where it may alter the responsiveness of sympathetic preganglionics and as a result the rate of efferent sympathetic nerve impulses may become increased. However, it should be realized that the results of several Vascular Medicine 1998; 3: 207-214 studies suggest that the rate of efferent sympathetic nerve impulses within the affected extremity of RSD patients is decreased rather than increased. First, it has been demonstrated that venous plasma levels of noradrenaline 54 and neuropeptide Y 55 (which co-exists with noradrenaline in sympathetic nerve terminals) collected in the affected limb of RSD patients are decreased when compared with plasma samples obtained from the contralateral (unaffected) extremity. Secondly, the sympathetically mediated vasoconstrictor response of skin microvessels, which is evoked by changing the position of the hand from heart level to dependency, is impaired at all three clinical stages of RSD. 56 This finding is also indicative of sympathetic denervation. 57 It has been suggested that (partial) sympathetic denervation may also account for the increase in skin blood flow that is observed at an early stage of RSD. 17 If the level of efferent sympathetic nerve impulses within the affected extremity of RSD patients is indeed decreased rather than increased, how does this fit within the hypothesis of an abnormal interaction between the sensory and sympathetic nervous system? It has been demonstrated that sympathetic denervation increases the sensitivity of blood vessels to catecholamines. 58 Hence, it would be expected that blood vessels within the affected extremity of RSD patients develop supersensitivity to catecholamines. The latter hypothesis has been confirmed by Arnold et al, 59 who demonstrated increased venous ␣-adrenoceptor responsiveness. It has been suggested that this (vascular) supersensitivity to catecholamines accounts for the decrease in skin blood flow as observed at later stages of RSD. 17 It is tempting to consider the possibility that the involvement of the sympathetic nervous system in the development and/or maintenance of sensory abnormalities of RSD patients also consists of supersensitivity to catecholamines consequent upon sympathetic denervation (to which probably not only blood vessels but also sensory nerve fibres are subjected). Consequently, an increase in the number and/or responsiveness of axonal adrenoceptors may develop in peripheral nerves. The latter hypothesis is supported by the findings of Drummond et al, 60 who demonstrated an increase in the number of ␣ 1 -adrenoceptors in the hyperalgesic skin of RSD patients. Since arterioles, sweat glands and hair follicles were excluded from analysis, it is likely that this finding is indicative of an increased number of ␣ 1 -adrenoceptors in fine intra-epidermal nerve fibres.
Several studies have reported relief of pain following sympathectomy in some RSD patients. 52, 53 This finding seemingly argues against the concept that sympathetic dysfunction in RSD patients consists of denervation-induced supersensitivity to catecholamines. However, it is most likely that in patients with partial nerve injury (as is the case in RSD/causalgia) the extent of sympathetic denervation is not complete. Hence, a chemical or surgical sympathectomy may even further reduce the amount of noradrenaline released (prejunctionally) into the synaptic cleft. Nevertheless, in the long run, these sympathectomies may even further increase the level of supersensitivity to catecholamines. The latter phenomenon may account for the clinical observation that in certain RSD patients who are subjected to paravertebral sympathetic ganglionectomy relief is only transient.
Neurogenic inflammation
The presence of spontaneous and stimulus-induced pain in RSD patients indicates high levels of discharge from many of the injured nerve's afferents towards the central nervous system. Little, however, is known about the effects of partial nerve injury on the efferent function of sensory nerve fibres. In 1920, Lewis 61 hypothesized that several inflammatory symptoms commonly observed in RSD patients result from release of pain-producing vasodilator substances at the endings of sensory nerve fibres as a result of excitation of these nerve fibres somewhere at axonal level. This author investigated in detail the sequence of events induced by mechanical excitation of sensory nerve fibres (firmly stroking the human skin with a blunt instrument). The observed response was referred to as the triple response: (1) the red reaction due to local dilatation of skin microvessels; (2) the flare, a widespread dilatation of neighbouring arterioles brought about by a local axon reflex and accompanied by hyperalgesia; and (3) the wheal, i.e. local increased permeability of skin microvessels. Collectively, these signs and symptoms are being referred to as neurogenic inflammation. Following studies have demonstrated that not only mechanical but also chemical 62 and electrical 63 excitation of sensory nerve fibres somewhere at axonal level may provoke neurogenic inflammation. Thus, noxious stimulation of the skin of man leads not only to a flare response (redness of skin), but also to oedema and reduced pain thresholds both locally and more widespread. Substance P and other neuropeptides are considered to be the cardinal mediators of neurogenic inflammation. The neuropeptide substance P exerts its vasodilator effect through direct interaction with endothelial cells. In addition. substance P binds to mast cells, thus causing degranulation and release of inflammatory mediators, such as histamine. 64 Histamine acts indirectly on primary afferents to induce the release of other inflammatory mediators, and it may exert a direct vasodilator effect on the microvasculature. In addition to their vasodilator effects, neuropeptides have been reported to increase the excitability of primary sensory nerve fibres and to increase vascular permeability. 65 Hence, in neuropathic patients the alleged release of neuropeptides may be involved not only in vasomotor disturbances but also in altered nociception and oedema formation. It is also tempting to speculate that the neuropeptide effect of increasing vascular permeability contributes to the development of spontaneous discharges in and increased excitability of sensory nerve fibres: various substances (such as catecholamines), which normally are not able to pass the blood-nerve barrier, may become able to do so in the case of increased microvascular permeability. Unfortunately, experimental studies on the presence of neurogenic inflammation in RSD are scarce. Evidence in favour of an involvement of antidromically acting sensory nerve fibres in sensory abnormalities in nerve-injured patients was provided by the observation that local capsaicin application, which locally depletes substance P, may relieve pain in RSD patients. 66 
Experimental animal studies
It was not until 1988, that a rat model of partial peripheral nerve injury was developed in which signs and symptoms Vascular Medicine 1998; 3: 207-214 could be induced, reminiscent of those observed in RSD, through loose ligation of a sciatic nerve (chronic constriction injury (CCI)). 67 The latter procedure evokes partial and differential deafferentiation of the sciatic nerve's territory with survival of primary afferent neurons whose axons are interrupted and formation of a neuroma-in-continuity at the site of constriction.
The results of several studies indicate altered activity of the sympathetic nervous system in CCI rats. First, loose ligation of a sciatic nerve provokes dystrophic claw growth. 67 Secondly, this type of nerve injury provokes abnormalities of skin temperature and skin blood flow, not only on the ligated 68 but also on the non-ligated side. 69 The involvement of the sympathetic nervous system in sensory abnormalities in CCI rats is indicated by the observation that systemic administration of the sympatholytic drug guanethidine has an anti-nociceptive effect. 70 The exact nature of sympathetic dysfunction in CCI rats has been the subject of several studies. It has been demonstrated that, distal to the site of nerve injury, vascular sympathetic dysfunction consists of supersensitivity to catecholamines consequent upon partial sympathetic denervation. Sympathetic denervation was first demonstrated by Wakisaka et al. 71 These authors visualized (intramural) noradrenalinecontaining nerves (by means of glyoxylic acid) in subcutaneous arteries obtained from the hind paw of CCI rats and found a reduced density. 71 Secondly, the sympathetically mediated constrictor response of skin microvessels, which usually follows cooling of the rat abdomen, is impaired in the affected hind paw of CCI rats from an early stage after nerve injury onwards. 68 This is indicative of sympathetic denervation. 72 Thirdly, the decrease in skin blood flow observed at a later stage after nerve injury could not be over-ruled by chemical blockade (by means of lidocaine) of impulse conduction in the injured sciatic nerve. 73 Evidence for the presence of vascular supersensitivity to catecholamines was provided by a study on subcutaneous arteries that had been isolated from the hind paw of rats with 3-week-old CCI. 74 To this end, these arteries were mounted in a myograph following which contractile responses to various adrenergic agonists were recorded. The presence of vascular supersensitivity to catecholamines was confirmed by the observation that sensitivity to exogenously administered noradrenaline was increased.
CCI rats demonstrate increased skin temperature 75 and skin blood flow 68 in the affected hind paw at an early stage after nerve injury. This increase in skin blood flow can be abolished by application of capsaicin to the loosely ligated sciatic nerve. 73 Since capsaicin selectively blocks axoplasmic transport of neuropeptides as well as impulse propagation in sensory nerve fibres, this finding suggests that this early vasodilator response results from release of neuropeptides from distal terminals of primary afferent fibres. The latter hypothesis is supported by a study of Basile et al 76 who observed, in the affected hind paw of CCI rats, reduced vasodilation and plasma extravasation in response to substance P. These findings suggest decreased receptor numbers and/or effectiveness resulting from the release of large amounts of substance P from the peripheral endings of sensory nerves and are supported by the observation that substance P levels in the spinal dorsal horn of CCI rats are decreased. 77 Neuropeptides cause not only vasodilation but also other inflammatory phenomena such as increased vascular permeability and tissue accumulation of polymorphonuclear leucocytes. Additional evidence for the presence of (increased) release of neuropeptides in CCI rats was provided by a study which demonstrated the presence of the latter two phenomena in muscle biopsies obtained from the affected hind paw. 78
Future therapeutic modalities
The observed phenomenon of denervation-induced supersensitivity to catecholamines suggests that blockade of adrenoceptors may relieve pain in RSD patients. An advantage of blockade of adrenoceptors over chemical or surgical sympathectomy could be that the long-term results of the latter may be negatively influenced by a further increase in (super-) sensitivity to catecholamines. Also, in cases where sympathetic denervation is already (sub-) complete as a result of the initiating event, a few beneficial effects of sympathectomy may be expected, whereas blockade of adrenoceptors may still be advantageous. A disadvantage of the aforementioned non-selective ␣-adrenoceptor blockers is that they may have serious side-effects (such as hypotension), which may prohibit adequate dosage for pain relief. It is likely however, that sensory abnormalities induced by partial nerve injury are mediated by a subset of adrenoceptors. The latter hypothesis is supported by the observation that prazosin 79 relieves pain in RSD patients suggesting that it is ␣ 1 -adrenoceptor mediated. Further determination of the subtype of the ␣ 1 -adrenoceptor involved in mediation of pain may yield the possibility of an even more selective blockade.
The concept that neurogenic inflammation plays a role in RSD also raises the possibility of new therapeutic approaches. For example, capsaicin, which provokes a profound and apparently irreversible abolition of the capability of sensory fibres to mediate a neurogenic inflammatory response, may be applied perineurally or topically (to the affected skin). Likewise, neuropeptide-receptor blockers may reduce neurogenic inflammation.
